BluGlass (BLG) H2 2026 earnings summary

Executive summary

• FY26 marked a pivotal year with a refreshed Board, recapitalisation, and a sharpened commercial strategy focused on visible GaN lasers for defence, aerospace, quantum, and AI infrastructure sectors.

• Secured $14.6 million in new capital via placement, options, and shortfall agreement, with significant Board and management participation.

• Transitioned from legacy foundry services to higher-value project and product revenues, validating the project-to-product strategy.

Financial highlights

• Total revenue, finance income, and other income: $10.5 million, down 10% year-over-year due to strategic exit from legacy services and delayed US government contracts.

• Net loss for the year: $10,390,851, a 5% improvement from prior year.

• Cash and cash equivalents: $11.3 million at year-end, up 98% from previous year.

• Net assets increased 24% to $14.4 million.

• No dividends declared for FY26 or FY25.

Outlook and guidance

• Focus remains on converting a US$100 million project pipeline into revenue-generating contracts, especially in defence, aerospace, quantum, and biotech sectors.

• Continued expansion in the US market and pursuit of non-dilutive government funding.

• Ongoing investment in technology, equipment, and personnel to accelerate commercialisation.